Alan P. Johnson

Sort by:

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Neil Woodford, Michael E Ward, +14 authors David Martin Livermore
The Journal of antimicrobial chemotherapy
2004

OBJECTIVES During 2003, the Health Protection Agency's Antibiotic Resistance Monitoring and Reference Laboratory began to receive isolates of Escherichia coli for confirmation of extended-spectrum… (More)

Surveillance and epidemiology of MRSA bacteraemia in the UK.

Alan P. Johnson, Andrew M Pearson, Georgia J Duckworth
The Journal of antimicrobial chemotherapy
2005

Surveillance of bacteraemia caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK has involved collection of data from hospital microbiology laboratories via several mechanisms,… (More)

Current perspectives on glycopeptide resistance.

Neil Woodford, Alan P. Johnson, Donald Morrison, David C.E. Speller
Clinical microbiology reviews
1995

In the last 5 years, clinical isolates of gram-positive bacteria with intrinsic or acquired resistance to glycopeptide antibiotics have been encountered increasingly. In many of these isolates,… (More)

VANCOMYCIN-RESISTANT ENTEROCOCCI

AnneH. C. Uttley, Neil Woodford, Alan P. Johnson, Barry Cookson, Robert C. George
The Lancet
1988

Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance.

Alan P. Johnson, Neil Woodford
Journal of medical microbiology
2013

The rapidity with which new types of antibiotic resistance can disseminate globally following their initial emergence or recognition is exemplified by the novel carbapenemase New Delhi… (More)

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis.

Mark H. Reacher, Atit Shah, +8 authors Robert C. George
BMJ
2000

OBJECTIVES Determination of causes, trends, and antibiotic resistance in reports of bacterial pathogens isolated from blood in England and Wales from 1990 to 1998. DESIGN Description of bacterial… (More)

Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS).

Alan P. Johnson, Hazel M Aucken, +5 authors Barry D. Cookson
The Journal of antimicrobial chemotherapy
2001

Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals.

Stefan Schwarz, Peter Silley, +4 authors Wim Gaastra
The Journal of antimicrobial chemotherapy
2010

The accurate performance of antimicrobial susceptibility testing of bacteria from animal sources and the correct presentation of the results is a complex matter. A review of the published literature… (More)

Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales.

Michel Doumith, Gauri S. Godbole, +10 authors Neil Woodford
The Journal of antimicrobial chemotherapy
2016

OBJECTIVES In response to the first report of transmissible colistin resistance mediated by the mcr-1 gene in Escherichia coli and Klebsiella spp. from animals and humans in China, we sought to… (More)

High-level vancomycin-resistant enterococci causing hospital infections.

AnneH. C. Uttley, Robert C. George, +7 authors John P Heptonstall
Epidemiology and infection
1989

Nosocomial infection or colonization due to enterococci with high-level resistance to vancomycin (minimal inhibitory concentrations [MICs] between 64 and greater than 2000 mg/L) has occurred in 41… (More)

Filter Results:

Publication Year

Publication Type

Co-author

Journals and Conferences